13 research outputs found

    Scatter plot showing the four different clusters formed after hierarchical clustering of the ALL study sample using 20th percentile of metabolite levels as cutoff point.

    No full text
    <p>Data for 6-mMPNs and 6-TGNs are the metabolite levels (adjusted per dose/SA). Cluster A (i.e. above 20% cutoff point) was characterized by high levels of 6-TGN levels and 6-mMP levels (adherent patients). Cluster B was characterized by high levels of 6-mMP but with low 6-TGN concentrations, it is expected that those patients in Cluster B had higher TPMT activity than those in cluster A, which would explain the shift in 6-MP metabolism toward 6-mMP production in those patients. Cluster C was characterized by low levels of both 6-mMP levels and 6-TGN (non-adherent patients). Cluster D patients have low levels of 6-mMP levels and high levels of 6-TGN (Lower TPMT activity in patients in Cluster D compared to those in cluster A would explain the shift in 6-MP metabolism toward 6-TG production in those patients).</p

    Demographic and disease characteristics of the study sample (n = 52)<sup>*</sup>.

    No full text
    <p>Demographic and disease characteristics of the study sample (n = 52)<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0183119#t002fn001" target="_blank">*</a></sup>.</p
    corecore